Moors & Cabot, Inc. Vaxart, Inc. Transaction History

Moors & Cabot, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$0.75 - $2.24 $7,500 - $22,400	10,000 Added 100.0%	20,000 $19,000
Q4 2022 Feb 06, 2023	SELL	$0.75 - $2.24 $7,500 - $22,400	-10,000 Reduced 50.0%	10,000 $9,000
Q3 2022 Nov 07, 2022	BUY	$2.09 - $4.5 $20,900 - $45,000	10,000 Added 100.0%	20,000 $44,000
Q4 2021 Feb 14, 2022	BUY	$5.77 - $7.96 $57,699 - $79,600	10,000 New	10,000 $63,000

107

37.7M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $86M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.